NewYork-Presbyterian is home to one of the largest structural heart programs in the nation and has helped pioneer transcatheter valve replacement techniques.
Valve Disease Outcomes
NewYork-Presbyterian’s specialists in valvular heart disease are at the forefront of developing minimally invasive and catheter-based approaches to valve repair and replacement, influencing the field through clinical research that spans the medical, interventional and surgical arenas.
Aortic Valve Disease
At NewYork-Presbyterian, transcather therapy has become a mainstay of the treatment algorithm for structural heart disease. Over 4,000 TAVR procedures have been performed here since its introduction, and some 500 cases are performed annually by our heart teams.
Mitral Valve Disease
The technology and techniques now being studied in the treatment of mitral valve disease are providing patients who would have been excluded from treatment – the elderly or critically ill – the opportunity for meaningful therapy.